admin@ataxiatelangiectasia.es
Home
Bibliography
Authors
Cells and molecules
Clinical
Country
Diseases
Drugs
Experimental
Journals
Methods
Year
Resources
What is A-T?
News
Search
FDA
Enter Part of Title
Filter
Clear
Display #
5
10
15
20
25
30
50
100
All
ChromaDex wins orphan designation for rare ataxia drug
U.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasia
Search
Home
Bibliography
Authors
Cells and molecules
Clinical
Country
Diseases
Drugs
Experimental
Journals
Methods
Year
Resources
What is A-T?
News
admin@ataxiatelangiectasia.es